EpiPen patent revoked in Europe
marrio31 / iStockphoto.com
The US Food and Drug Administration (FDA) yesterday granted Teva approval for the first generic version of EpiPen (epinephrine), an autoinjector pen used for the emergency treatment of allergic reactions.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at email@example.com
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
FDA, Food and Drug Administration, generics, EpiPen, allergic reactions, approval, Scott Gottlieb, competition, Mylan